Study identifier:D3250R00116
ClinicalTrials.gov identifier:NCT06299306
EudraCT identifier:N/A
CTIS identifier:N/A
REACT – REAl Care for AsThma A disease study to identify patients with severe uncontrolled asthma using EMR pre-screening and AIRQ® score documentation over 12 months, including patient-documented OCS use with the AIRQ®-Active application
ASTHMA, BRONCHIAL
N/A
No
-
All
1650
Observational
18 Years - 120 Years
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Sept 2024 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|